Message #23 From:
NewsBot Date: November 3, 2006 07:49:00 AM
CEMI News Chembio Diagnostics to Present at the Paulson Investment's Westergaard Small Cap Conference November 6 and the Rodman & Renshaw Healthcare Conference on November 8, 2006
NEW YORK--(BUSINESS WIRE)--Chembio Diagnostics, Inc.’s (OTCBB:CEMI)
Lawrence Siebert, President and Chief Executive Officer, will be
presenting at Paulson Investment’s Westergaard
Small Cap Conference on November 6, 2006 at the Waldorf Astoria Hotel in
New York. Mr. Siebert will present in the morning session at 10:10 and
11:55 AM, and again in the afternoon session at 3:15 and 5:00 PM.
Mr. Siebert will also be presenting at the 2006 Rodman & Renshaw 8th
Annual Healthcare Conference, November 8, 2006 at the Palace Hotel, in
New York. The presentation is scheduled for 3:10 PM.
A live audio webcast of the presentation can be accessed on the dates of
the presentations at www.chembio.com,
and will be archived on the company’s website
for 30 days.
ABOUT CHEMBIO
Chembio Diagnostics, Inc., a developer and manufacturer of rapid
diagnostic tests for infectious diseases, is on the frontlines of the
global battle against the AIDS pandemic. The Company has received
marketing approval from the FDA for its SURE CHECK®HIV 1/2 and HIV 1/2 STAT-PAK™ rapid tests. The
Company also manufactures rapid tests for veterinary Tuberculosis and
Chagas Disease, and has developed a patent-pending technology, the Dual
Path Platform (DPP™), for its next generation
HIV and other rapid tests. For additional information please visit www.chembio.com.
FORWARD-LOOKING STATEMENTS
Statements contained herein that are not historical facts may be
forward-looking statements within the meaning of the Securities Act of
1933, as amended. Forward-looking statements include statements
regarding the intent, belief or current expectations of the Company and
its management.Such statements are estimates only, as the
Company has not completed the preparation of its financial statements
for those periods, nor has its auditor completed the audit of those
results. Actual revenue may differ materially from those anticipated in
this press release. Such statements reflect management's current views,
are based on certain assumptions and involve risks and uncertainties.
Actual results, events, or performance may differ materially from the
above forward-looking statements due to a number of important factors,
and will be dependent upon a variety of factors, including, but not
limited to Chembio's ability to obtain additional financing, to obtain
regulatory approvals in a timely manner, and the demand for Chembio's
products. Chembio undertakes no obligation to publicly update these
forward-looking statements to reflect events or circumstances that occur
after the date hereof or to reflect any change in Chembio's expectations
with regard to these forward-looking statements or the occurrence of
unanticipated events. Factors that may impact Chembio's success are more
fully disclosed in Chembio's most recent public filings with the U.S.
Securities and Exchange Commission.
